Acquired von Willebrand disease: management of labor and delivery with intravenous dexamethasone, continuous factor concentrate, and immunoglobulin infusion.

Abstract

Acquired von Willebrand disease is a rare bleeding disorder that can lead to complete absence of clotting factor 8 and von Willebrand factor. Recently, the hematologic literature has reported continuous infusion of factor concentrates and intravenous immunoglobulin as an improved therapy for active bleeding and prophylaxis in patients who are anticipating surgery with congenital von Willebrand disease. We describe the first case of a pregnant woman with acquired von Willebrand disease who underwent the described therapy during delivery.

• Authors: Heather S Lipkind, Jonathan D Kurtis, Raymond Powrie, Marshall W Carpenter
• Journal: American journal of obstetrics and gynecology (Am J Obstet Gynecol) Vol. 192 Issue 6 Pg. 2067-70 (Jun 2005) ISSN: 0002-9378 [Print] United States
• PMID: 15970901 (Publication Type: Case Reports, Journal Article)

Chemical References

• Immunoglobulins, Intravenous
• von Willebrand Factor

Topics

• Adult
• Diagnosis, Differential
• Female
• Humans
• Immunoglobulins, Intravenous (administration & dosage)
• Infant, Newborn
• Infusions, Intravenous
• Male
• Pregnancy
• Pregnancy Complications (diagnosis, drug therapy)
• Prenatal Diagnosis
• von Willebrand Diseases (diagnosis, drug therapy)
• von Willebrand Factor (administration & dosage)